Market Signal Report
BONUS: ELMT, BMM, ARMP — tungsten + FDA tape (before the bell) ‌
MARKET SIGNAL REPORT
POWERED BY STOCKSTOTRADE
MON SEP 14  Premarket   SPY ▼0.63%   QQQ ▼1.56%   IWM ▼0.44%

Dear Reader,

After the historic cancer vaccine met key goals in Phase 3 trials... Moderna's stock doubled in a single day. And Merck soared too.

Here's the stock that could be next...

According to a tech expert who helped manage $200 million for billionaire Steve Cohen's fund (owner of the New York Mets)... and who's personally met Elon Musk... the biotech stock that could soar next is NOT Moderna, Merck, or any stock you might expect.

The #1 play right now is a very different kind of company – directly tied into this story.

It holds the key to a new tech that could make Moderna and Merck's accomplishment look small by comparison...

This tech:

  • Is already backed by billionaires Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel.
  • Nvidia CEO Jensen Huang says it's about to have "the most dramatic impact" on our lives.
  • Anthropic's CEO says it could unlock 100 years of medical progress in the next 10 years alone.
  • And its impact on our health could be so dramatic... Nature Magazine says it could be worth $367 trillion to the global economy.

This new medical tech is already going live across the United States.

Before you wake up to the next big biotech gain – and miss out...

Click here to learn about the top way to play this new era of biotech and medicine.

Regards,

Whitney Tilson
Senior Editor, Stansberry Research

P.S. Remember, Moderna's stock doubled in a single day after one big announcement. That's why you'll want to move fast. Click here to see the next medical stock that could soar.

Indexes soft into the open. SPY 759.45 (−0.63%), QQQ 703.72 (−1.56%), IWM 287.62 (−0.44%). The Fly flagged Nasdaq futures −1.1% after an AI slowdown call overnight. Premarket prints, not the cash open.

Three small caps with wires: ELMT on a $450M DoW tungsten stake plus up to $2B Defense Logistics Agency contract, BMM on the Springer Tungsten co-invest, ARMP on FDA Breakthrough Therapy for AP-SA02. Trade the wires. Skip empty percent.

THE HEADLINE THAT MATTERS TODAY

 

Elmet Group soars after winning $2B U.S. tungsten contract, Pentagon makes $450M investment

SeekingAlpha via QuoteMedia | Sep 14, 2026 07:39 ET

TOP PRE-MARKET MOVERS

 

1 · ELMT +33.0% — 21.53 | ~2.93M | Nasdaq. GlobeNewswire 05:15 ET: $450M DoW investment + up to $2B DLA tungsten contract.

2 · BMM +16.9% — 6.38 | ~358k | Nasdaq. PR Newswire 05:30 ET: $150–175M Springer Tungsten Complex with ELMT.

3 · ARMP +9.7% — 5.90 | ~1.46M | NYSE American. PR Newswire 07:00 ET: FDA Breakthrough Therapy for AP-SA02.

Wall Street expert's top AI stock pick for Q3 and Q4 (From Brownstone Research)

HANDPICKED FOR YOU

 
Sponsored · Brownstone Research
Do you own oil stocks right now?
One analyst frames oil risk as a 40-year setup without owning oil.
See more
Sponsored · Millionaire Publishing
Space sector sold off — the window is open
IPO rotation into SPCX left names soft; two catalysts on the clock.
See more
Sponsored · Oxford Club
The energy math doesn't seem possible
A fingertip pellet vs coal, oil, and gas — the power-density frame.
See more

SHH. THIS IS A CLUB.

You only get the morning tape because you actually open and click. Go quiet and we give your chair to someone who won't. No waitlist. No apology.

Market Signal Report
powered by StocksToTrade

Signal over noise. Soft open. ELMT tungsten tape.

Keep Reading

View more
caret-right